Literature DB >> 30396980

Relationship Between Postoperative CRP and Prognosis in Thoracic Esophageal Squamous Cell Carcinoma.

Keita Katsurahara1, Atsushi Shiozaki2, Hitoshi Fujiwara1, Hirotaka Konishi1, Michihiro Kudou1, Katsutoshi Shoda1, Tomohiro Arita1, Toshiyuki Kosuga1, Ryo Morimura1, Yasutoshi Murayama1, Yoshiaki Kuriu1, Hisashi Ikoma1, Takeshi Kubota1, Masayoshi Nakanishi1, Kazuma Okamoto1, Eigo Otsuji1.   

Abstract

BACKGROUND/AIM: Few studies have examined postoperative CRP in esophageal cancer. We investigated the relationship between postoperative CRP values according to the postoperative period and prognosis in esophageal cancer. PATIENTS AND METHODS: We performed a retrospective cohort study including 187 patients who underwent esophagectomy for esophageal squamous cell carcinoma (ESCC) between January 2008 and October 2016.
RESULTS: CRP within 1 month of surgery was not related to overall survival (OS) or recurrence-free survival (RFS). In a univariate analysis, postoperative 2 months (2M)-CRP ≥0.15 ml/dl was associated with poorer OS (41.4 vs. 71.4%, p=0.0002) and RFS (28.9 vs. 51.3%, p=0.007). In a multivariate analysis, 2M-CRP ≥0.15 ml/dl was an independent factor for poorer OS (HR=2.27, 95%CI=1.03-3.34, p=0.005) and RFS (HR=1.65, 95%CI=1.08-2.52, p=0.020). The incidence of postoperative pneumonia was significantly higher in the 2M-CRP ≥0.15 ml/dl group (p=0.026).
CONCLUSION: 2M-CRP ≥0.15 ml/dl is an independent prognostic factor for ESCC. Furthermore, postoperative pneumonia may be associated with patient prognosis after esophagectomy. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Postoperative CRP; esophageal cancer

Mesh:

Substances:

Year:  2018        PMID: 30396980     DOI: 10.21873/anticanres.13016

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Perioperative Predictive Markers for Recurrence of Esophageal Cancer after Esophagectomy.

Authors:  Yoshinori Fujiwara; Masaharu Higashida; Hisako Kubota; Yuko Okamoto; Shumei Mineta; Shunji Endo; Tomio Ueno
Journal:  Gastrointest Tumors       Date:  2021-03-17

Review 2.  Bacterial Translocation in Gastrointestinal Cancers and Cancer Treatment.

Authors:  Keita Kouzu; Hironori Tsujimoto; Yoji Kishi; Hideki Ueno; Nariyoshi Shinomiya
Journal:  Biomedicines       Date:  2022-02-04

3.  Nomogram constructed by immunological and inflammatory indicators for predicting prognosis of patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy plus surgery.

Authors:  Yun Luo; Xue-Fen Weng; Jia-Tao Huang; Xue-Hao Hu; Lai-Feng Wei; Yi-Wei Lin; Tian-Yan Ding; Biao Zhang; Ling-Yu Chu; Can-Tong Liu; Yu-Hui Peng; Yi-Wei Xu; Fang-Cai Wu
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.